InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by McNeill Jonathan, Executive. Director active across 2 companies, notably Dyne Therapeutics, Inc.. Aggregated, 25 disclosures have been recorded. Split: 0 buy · 14 sells. Total volume traded: €807k. History available since 20 September 2021. The latest transaction was filed on 19 August 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to McNeill Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
20,549 sharesOrdinary SharesSEC:0001628280-26-044885:0
19,507 sharesOrdinary SharesSEC:0001628280-25-057678:0
2,400 shares@ US$45.017.5% of flowCommon StockSEC:0000950170-24-099127:0
1,823 shares@ US$31.344.1% of flowCommon StockSEC:0000950170-24-072151:0
2,279 shares@ US$28.204.5% of flowCommon StockSEC:0000950170-24-062075:0
86,159 shares@ US$5.5433.5% of flowCommon StockSEC:0000950170-24-030484:0
2,434 shares@ US$25.854.4% of flowCommon StockSEC:0000950170-24-029607:0
4,268 shares@ US$0.730.2% of flowCommon StockSEC:0000950170-24-024299:0
20,000 shares@ US$0.731.0% of flowCommon StockSEC:0000950170-24-008062:0
11,900 shares@ US$13.1010.9% of flowCommon StockSEC:0000950170-24-002278:0
1,245 shares@ US$10.721.0% of flowCommon StockSEC:0001209191-23-058330:0
96,158 shares0Common StockSEC:0001209191-23-055530:0
1,261 shares@ US$9.412.6% of flowCommon StockSEC:0001209191-23-050173:0
1,266 shares@ US$10.410.9% of flowCommon StockSEC:0001209191-23-049360:0
1,000 shares@ US$13.000.9% of flowCommon StockSEC:0001209191-23-037167:0
1,000 shares@ US$13.000.9% of flowCommon StockSEC:0001209191-23-018981:0
10,000 shares@ US$0.730.5% of flowCommon StockSEC:0001209191-23-004345:0
30,150 shares@ US$11.5725.2% of flowCommon StockSEC:0001209191-23-003013:0
40,000 shares0Common StockSEC:0001209191-22-060972:0
1,246 shares@ US$13.701.3% of flowCommon StockSEC:0001209191-22-050891:0
494 shares@ US$14.050.5% of flowCommon StockSEC:0001209191-22-050122:0
504 shares@ US$4.950.2% of flowCommon StockSEC:0001209191-22-037150:0
481 shares@ US$8.730.3% of flowCommon StockSEC:0001209191-22-018536:0
25,311 shares0Common StockSEC:0001209191-21-069425:0
545 shares@ US$15.610.6% of flowCommon StockSEC:0001209191-21-057325:0
25 of 25 declarations
About McNeill Jonathan
McNeill Jonathan is an executive, with 25 filings in total. The 25 filings in the recent sample run from 2021-09-22 to 2026-06-23, and the disposals observed in that recent sample total 833587 EUR, with no purchases reported. His listed companies are Dyne Therapeutics, Inc., where he is Chief Business Officer, and CRESCENT BIOPHARMA, INC., where he is President and COO.
